Health and Healthcare

Biogen : BIIB

All Biogen Articles

606 Articles

Chris Lange | Jul 13, 2016 at 8:10 AM EDT

Short Sellers Become More Selective on Major Biotechs

The June 30 short interest data have been compared with the previous report, and short interest moves were mixed in…

Jon C. Ogg | Jun 28, 2016 at 12:01 PM EDT

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

[cnxvideo id=”655353″ placement=”ros”]Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently…

Chris Lange | Jun 27, 2016 at 7:55 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of…

Paul Ausick | Jun 22, 2016 at 4:04 PM EDT

Verifone, Biogen Crash Wednesday’s 52-Week Low Club

June 22, 2016: Here are four stocks trading with relatively heavy volume among 40 equities making new 52-week lows in…

Chris Lange | Jun 12, 2016 at 10:20 AM EDT

7 Biopharma Companies That Destroyed Shareholders Last Week

Biotech companies that lost their way last week truly burned shareholders, whether it was due to ASCO, earnings or even…

Chris Lange | Jun 10, 2016 at 8:10 AM EDT

Short Sellers Become More Selective on Major Biotechs

The May 31 short interest data have been compared with the previous report, and short interest moves were mixed in…

Chris Lange | Jun 7, 2016 at 11:10 AM EDT

Biogen Stumbles Over Missed Mid-Stage Results

Shares of Biogen slumped early in Tuesday's session following the release of less-than-favorable top-line results from its mid-stage clinical study…

Chris Lange | May 25, 2016 at 8:20 AM EDT

Short Sellers Grow More Selective on Major Biotechs

The May 13 short interest data have been compared with the previous report, and short interest moves were mixed in…

Lee Jackson | May 12, 2016 at 8:20 AM EDT

4 Large Cap Growth Stocks to Buy With Incredible 10-Year Track Records

A new JPMorgan research report highlights some large cap secular growth stocks that have shown strong and consistent revenue growth…

Chris Lange | May 11, 2016 at 8:15 AM EDT

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the April 29 settlement date, and short interest moves were mixed in these…

Chris Lange | Apr 27, 2016 at 8:10 AM EDT

Short Sellers Run for Cover From Major Biotechs

The April 15 short interest data have been compared with the previous report, and short interest decreased across the board…

Chris Lange | Apr 12, 2016 at 9:55 AM EDT

Short Sellers Run for Cover From Major Biotechs

The March 31 short interest data have been compared with the previous report, and short interest decreased across the board…

Chris Lange | Apr 6, 2016 at 10:05 AM EDT

5 Biotechs With the Most Upside This Earnings Cycle

Despite a modest erosion to fundamentals and sector headwinds, Jefferies does not anticipate any dramatic earnings misses, which could help…

Chris Lange | Mar 10, 2016 at 8:05 AM EST

Short Sellers Back Off of Major Biotechs

The February 29 short interest data have been compared with the previous report, and short interest decreased across the board…

Jon C. Ogg | Feb 25, 2016 at 5:15 PM EST

Why Citi Sees Huge Upside in 4 Top Biotechs Now

Citigroup came out with a biotech upgrade of sorts on Thursday. The firm issued brand new Buy ratings on four…

1 … 19 20 21 22 23 … 41

Biogen : BIIB

All Biogen Articles

Short Sellers Become More Selective on Major Biotechs

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

Short Sellers Run for Cover From Major Biotechs

Verifone, Biogen Crash Wednesday’s 52-Week Low Club

7 Biopharma Companies That Destroyed Shareholders Last Week

Short Sellers Become More Selective on Major Biotechs

Biogen Stumbles Over Missed Mid-Stage Results

Short Sellers Grow More Selective on Major Biotechs

4 Large Cap Growth Stocks to Buy With Incredible 10-Year Track Records

Short Sellers Run for Cover From Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Short Sellers Run for Cover From Major Biotechs

5 Biotechs With the Most Upside This Earnings Cycle

Short Sellers Back Off of Major Biotechs

Why Citi Sees Huge Upside in 4 Top Biotechs Now

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Biogen : BIIB

All Biogen Articles

Short Sellers Become More Selective on Major Biotechs

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

Short Sellers Run for Cover From Major Biotechs

Verifone, Biogen Crash Wednesday’s 52-Week Low Club

7 Biopharma Companies That Destroyed Shareholders Last Week

Short Sellers Become More Selective on Major Biotechs

Biogen Stumbles Over Missed Mid-Stage Results

Short Sellers Grow More Selective on Major Biotechs

4 Large Cap Growth Stocks to Buy With Incredible 10-Year Track Records

Short Sellers Run for Cover From Major Biotechs

Short Sellers Run for Cover From Major Biotechs

Short Sellers Run for Cover From Major Biotechs

5 Biotechs With the Most Upside This Earnings Cycle

Short Sellers Back Off of Major Biotechs

Why Citi Sees Huge Upside in 4 Top Biotechs Now

This High-Yield Emerging Funds ETF Offers International Diversification

A 71-Year-Old’s $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy’s 25% Savings Rule Actually Starts at 15%

Featured Reads

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

Why The Money Guy's 25% Savings Rule Actually Starts at 15%